- Home
- SLNO vs DBD Comparison
SLNO vs DBD Comparison
Compare SLNO & DBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SLNO | DBD |
|---|---|---|
| Founded | 1999 | 1859 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.1B |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | SLNO | DBD |
|---|---|---|
| Price | $49.87 | $66.68 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 3 |
| Target Price | ★ $110.90 | $76.67 |
| AVG Volume (30 Days) | ★ 1.6M | 207.4K |
| Earning Date | 11-04-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 43573.14 |
| EPS | N/A | ★ 1.35 |
| Revenue | $98,675,000.00 | ★ $3,690,400,000.00 |
| Revenue This Year | N/A | $2.72 |
| Revenue Next Year | $155.86 | $2.15 |
| P/E Ratio | ★ N/A | $50.15 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $41.50 | $34.88 |
| 52 Week High | $90.32 | $68.59 |
Technical Indicators
Market Signals| Indicator | SLNO | DBD |
|---|---|---|
| Relative Strength Index (RSI) | 46.19 | 60.09 |
| Support Level | $48.60 | $66.57 |
| Resistance Level | $55.47 | $68.59 |
| Average True Range (ATR) | 2.79 | 1.62 |
| MACD | 0.67 | 0.10 |
| Stochastic Oscillator | 42.12 | 64.92 |
Price Performance
Historical ComparisonAbout SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.
About DBD Diebold Nixdorf Incorporated
Diebold Nixdorf Inc is engaged in providing software and hardware services for financial and retail industries. The customer segments of the company are Banking, which offers integrated solutions for financial institutions, and Retail, which offers solutions, software, and services that improve the checkout process for retailers. A majority of its revenue is generated from the Banking segment. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA), followed by the Americas and the Asia-Pacific region.